Mark Reed, DPM

  • Placentia, CA
  • Podiatrist
NPI1891771713PAC ID6305868274
Medicare patients, 2024
225
Part D claims, 2024
266
MIPS score, 2024
98
Hospital affiliations
1
Industry payments
$134
Practice address
1301 N Rose Drive, Placentia, CA 92870
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UCI Health - Placentia Linda

Hospital · Placentia, California

See all 3 affiliations

Find Mark Reed's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Mark Reed is a podiatrist in Placentia, California

Mark Reed practices at UCI Health - Placentia Linda in Placentia, California, part of UC Irvine.

Mark Reed's NPI, 1891771713, was assigned on December 22, 2005. Mark Reed graduated from California School of Podiatric Medicine in 1991. Mark Reed holds California license E3696.

NPI and contact details
Medicare PAC ID
6305868274
NPI enumeration date
December 22, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
61
Medical school graduation
1991

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Mark Reed practices at UCI Health - Placentia Linda in Placentia, California

Mark Reed's primary practice is UCI Health - Placentia Linda, at 1301 N Rose Drive, Placentia, CA 92870.

Source: Dmand AI Affiliation Data

Mark Reed is affiliated with 2 sites of care and 1 medical group

Mark Reed's primary practice is UCI Health - Placentia Linda in Placentia, California, part of UC Irvine. The medical group on file is Podiatry Hotline Foot & Ankle. Dmand AI also links Mark Reed to 1 more hospital outpatient department, named with a free account.

See all 3 affiliations for Mark Reed

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Mark Reed's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Reed practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UCI Health - Placentia LindaAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Mark Reed practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across UC Irvine and 6.2K+ hospitals, with verified contacts in the same login.

Mark Reed is one of 745 podiatrists in California

Podiatrist is Mark Reed's primary specialty in the NPI Registry, under taxonomy code 213E00000X. Mark Reed is licensed in California.

Specialties and state licenses

  • Podiatrist, CaliforniaPrimaryLicense E3696 · taxonomy 213E00000X

Podiatrists near Mark Reed

Counts of podiatrists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Mark Reed treated 225 Medicare patients in 2024, average age 75

CMS counts 225 Medicare patients who saw Mark Reed in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Reed's median patient age at 63, with 48% women.

Medicare patients, 2024225
Average age75
Average risk score1.33
Also on Medicaid10%

Mark Reed's Medicare patients by age, 2024

Mark Reed's Medicare patients by sex, 2024

  • Women11953%
  • Men10647%

Chronic conditions among Mark Reed's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure70%
  3. Arthritis56%
  4. Diabetes28%
  5. Ischemic heart disease28%
  6. Anxiety21%
  7. Chronic kidney disease20%
  8. Osteoporosis19%

Share of Medicare patients with each condition. A patient can have several.

Mark Reed's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women48%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Mark Reed wrote 266 Medicare Part D claims in 2024

In 2024, Mark Reed wrote 266 Medicare Part D claims for 74 patients. 100% of them were for generic drugs.

Part D claims, 2024266
Part D patients74

Mark Reed's Part D claims by kind of drug, 2024

  • Generic265 claims100%
  • Brand-name and other1 claims0%

Drug classes CMS tracks in Mark Reed's Part D claims, 2024

  • Antibiotics30%81 of 266 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Mark Reed scored 98 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Mark Reed for performance year 2024, reported individually. Mark Reed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 318 procedures of removal of tissue by Mark Reed, more than 95% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Mark Reed's MIPS scores, performance year 2024

  • 98of 100Final score
  • 95of 100Quality
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Mark Reed ranks in Medicare procedure volume

Removal of tissue
95th percentile318 procedures
Removal of nail tissue
62nd percentile26 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find podiatrists like Mark Reed by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Mark Reed received $134 in industry payments in 2025

CMS Open Payments shows 1 general payment to Mark Reed from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Paragon 28, Inc. paid the most, $134.

Companies that paid Mark Reed the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Mark Reed

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Mark Reed graduated from California School of Podiatric Medicine

Mark Reed graduated from California School of Podiatric Medicine in 1991.

  1. Medical schoolCalifornia School of Podiatric Medicine

Source: Dmand AI Professional Profile Data

Sources for Mark Reed's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Mark Reed

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Mark Reed's NPI number?

Mark Reed's NPI number is 1891771713. It was assigned on December 22, 2005, and it is active in the NPI Registry.

What does Mark Reed specialize in?

Mark Reed is a podiatrist in Placentia, California. The primary specialty in the NPI Registry is Podiatrist (taxonomy code 213E00000X).

Where does Mark Reed practice?

Mark Reed practices at 1301 N Rose Drive, Placentia, CA 92870. Mark Reed's primary practice is UCI Health - Placentia Linda in Placentia, California, part of UC Irvine. Dmand AI also links Mark Reed to 1 hospital outpatient department.

What is Mark Reed's medical license number?

Mark Reed holds California license E3696.

Which hospitals is Mark Reed affiliated with?

Mark Reed practices at UCI Health - Placentia Linda in Placentia, California.

What medical group is Mark Reed part of?

Mark Reed is linked to Podiatry Hotline Foot & Ankle.

Does Mark Reed accept Medicare?

Yes. CMS lists Mark Reed as accepting Medicare assignment.

What is Mark Reed's MIPS score?

Mark Reed's MIPS final score for performance year 2024 is 98 out of 100, reported individually.

How many Medicare patients does Mark Reed see?

CMS counts 225 Medicare patients who saw Mark Reed in 2024, with an average age of 75.

Where did Mark Reed go to medical school?

Mark Reed graduated from California School of Podiatric Medicine in 1991.

Has Mark Reed received payments from drug or device companies?

CMS Open Payments shows $134 in general payments to Mark Reed from 1 company from 2025 to 2025. The largest total came from Paragon 28, Inc.

How long has Mark Reed been practicing?

Mark Reed graduated from medical school in 1991, 35 years ago.

Selling to podiatrist practices?

See podiatrists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)